Sara Samadzadeh

15.3k total citations
61 papers, 357 citations indexed

About

Sara Samadzadeh is a scholar working on Neurology, Cellular and Molecular Neuroscience and Pathology and Forensic Medicine. According to data from OpenAlex, Sara Samadzadeh has authored 61 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Neurology, 20 papers in Cellular and Molecular Neuroscience and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Sara Samadzadeh's work include Botulinum Toxin and Related Neurological Disorders (23 papers), Hereditary Neurological Disorders (19 papers) and Neurological disorders and treatments (18 papers). Sara Samadzadeh is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (23 papers), Hereditary Neurological Disorders (19 papers) and Neurological disorders and treatments (18 papers). Sara Samadzadeh collaborates with scholars based in Germany, Denmark and United States. Sara Samadzadeh's co-authors include Harald Hefter, Dietmar Rosenthal, Philipp Albrecht, Samuel W. French, Brittany Tillman, B.A. French, John‐Ih Lee, Marek Moll, Sven G. Meuth and Nikoo F. Afifiyan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Sara Samadzadeh

52 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Samadzadeh Germany 13 158 75 67 61 52 61 357
Fayun Hu China 13 195 1.2× 40 0.5× 145 2.2× 102 1.7× 36 0.7× 41 476
Yanming Xu China 12 207 1.3× 43 0.6× 99 1.5× 11 0.2× 58 1.1× 25 355
Kiandokht Keyhanian United States 11 199 1.3× 20 0.3× 34 0.5× 89 1.5× 81 1.6× 19 398
B Hemmer United States 9 149 0.9× 50 0.7× 33 0.5× 37 0.6× 48 0.9× 18 371
Anthony G. Alessi United States 8 247 1.6× 135 1.8× 65 1.0× 34 0.6× 94 1.8× 14 584
Marina Gerbin United States 12 356 2.3× 222 3.0× 46 0.7× 28 0.5× 62 1.2× 18 496
Alicia Zha United States 13 69 0.4× 48 0.6× 99 1.5× 30 0.5× 76 1.5× 33 421
Gabriel S. Gonzales-Portillo United States 6 231 1.5× 44 0.6× 109 1.6× 22 0.4× 196 3.8× 12 531
Takamura Nagasaka Japan 11 138 0.9× 92 1.2× 18 0.3× 17 0.3× 106 2.0× 52 345

Countries citing papers authored by Sara Samadzadeh

Since Specialization
Citations

This map shows the geographic impact of Sara Samadzadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Samadzadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Samadzadeh more than expected).

Fields of papers citing papers by Sara Samadzadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Samadzadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Samadzadeh. The network helps show where Sara Samadzadeh may publish in the future.

Co-authorship network of co-authors of Sara Samadzadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Samadzadeh. A scholar is included among the top collaborators of Sara Samadzadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Samadzadeh. Sara Samadzadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samadzadeh, Sara, Fiona Chan, Friedemann Paul, et al.. (2025). The impact of autoimmune comorbidities on the onset attack recovery in adults with AQP4-NMOSD and MOGAD. Journal of Neurology. 272(7). 453–453.
2.
Ricigliano, Vito A. G., Silvia Marenna, Valentina Camera, et al.. (2025). Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of Progress. Biomedicines. 13(2). 357–357. 3 indexed citations
3.
Chan, Fiona, Sara Samadzadeh, Nasrin Asgari, et al.. (2025). Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGAD. Multiple Sclerosis Journal. 31(6). 658–667.
4.
Samadzadeh, Sara & Roy D. Sleator. (2025). The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: Advancing clinical applications.. eNeurologicalSci. 38. 100550–100550. 5 indexed citations
5.
Samadzadeh, Sara, et al.. (2024). At home e-based physical exercise programs in patients with multiple sclerosis: a scoping review. Frontiers in Neurology. 15. 1449519–1449519.
6.
Samadzadeh, Sara, Joachim Havla, Klaudia Lepka, et al.. (2024). High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis. Frontiers in Immunology. 15. 1458458–1458458.
7.
Samadzadeh, Sara, et al.. (2023). Analysis of walking, single-leg hopping and running in long-term treated Wilsońs disease. Journal of the Neurological Sciences. 455. 122766–122766.
8.
Hefter, Harald, et al.. (2023). Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study. Toxins. 15(7). 431–431. 5 indexed citations
11.
Hefter, Harald, Dietmar Rosenthal, Hans Bigalke, et al.. (2022). Significantly lower antigenicity of incobotulinumtoxin than abo- or onabotulinumtoxin. Journal of Neurology. 270(2). 788–796. 15 indexed citations
12.
Samadzadeh, Sara, et al.. (2021). Mildly Impaired Foot Control in Long-Term Treated Patients with Wilson’s Disease. Journal of Functional Morphology and Kinesiology. 7(1). 5–5. 3 indexed citations
13.
14.
Lee, John‐Ih, Sara Samadzadeh, Marek Moll, et al.. (2020). Long‐term adherence and response to botulinum toxin in different indications. Annals of Clinical and Translational Neurology. 8(1). 15–28. 18 indexed citations
15.
Hefter, Harald, et al.. (2020). Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy. Frontiers in Neurology. 11. 588395–588395. 9 indexed citations
16.
Nguyen, Luan, Sara Samadzadeh, Brittany Tillman, et al.. (2018). Alcoholic hepatitis versus non-alcoholic steatohepatitis: Levels of expression of some proteins involved in tumorigenesis. Experimental and Molecular Pathology. 104(1). 45–49. 13 indexed citations
17.
Afifiyan, Nikoo F., et al.. (2017). The role of Tec kinase signaling pathways in the development of Mallory Denk Bodies in balloon cells in alcoholic hepatitis. Experimental and Molecular Pathology. 103(2). 191–199. 10 indexed citations
18.
Afifiyan, Nikoo F., et al.. (2017). Over expression of proteins that alter the intracellular signaling pathways in the cytoplasm of the liver cells forming Mallory-Denk bodies. Experimental and Molecular Pathology. 102(1). 106–114. 13 indexed citations
19.
Khazaie, Habibolah, Mohammad R. Saidi, Amir A. Sepehry, et al.. (2011). Abnormal ECG Patterns in Chronic Post-War PTSD Patients: A Pilot Study. International Journal of Behavioral Medicine. 20(1). 1–6. 19 indexed citations
20.
Khazaie, Habibolah, Masoud Tahmasian, Mohammad Rasoul Ghadami, et al.. (2010). The Effects of Chronic Partial Sleep Deprivation on Cognitive Functions of Medical Residents. SHILAP Revista de lepidopterología. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026